WHO ICTRP trial
A Single Arm Prospective Trial of Combining CyberKnife Fractionated Radiosurgery…
ChiCTR2000037301 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2000037301 |
|---|---|
| Public title | A Single Arm Prospective Trial of Combining CyberKnife Fractionated Radiosurgery and PD-1 Inhibitor Nivolumab in the Treatment of Limited Number (=4) of Symptomatic Non-small-cell Lung Cancer Brain Metastases without Driver Mutations |
| Scientific title | A Single Arm Prospective Trial of Combining CyberKnife Fractionated Radiosurgery and PD-1 Inhibitor Nivolumab in the Treatment of Limited Number (=4) of Symptomatic Non-small-cell Lung Cancer Brain Metastases without Driver Mutations |
| Primary sponsor | Huashan Hospital, Fudan University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | lung cancer |
| Interventions | trial group:CyberKnife;trial group:PD-L1 inhibitor |
| Registration date | Aug 27, 2020 |
| Target size | trial group:36;trial group:36 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: